sur The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Group Discloses Stake in Mural Oncology PLC
The Vanguard Group, Inc. has filed a Form 8.3 disclosure revealing its stake in Mural Oncology PLC. This disclosure, required under the Irish Takeover Panel Act, outlines Vanguard's interests in relevant securities. As of October 6, 2025, Vanguard owned 288,779 ordinary shares in Mural Oncology, representing 1.67% of the company's shares.
In addition, Vanguard reported minor trading activity, purchasing 304 shares and selling 64 shares at a price of 2.08 USD per share. No cash-settled or stock-settled derivatives transactions were reported, and no indemnity or other dealing arrangements were noted.
Vanguard has confirmed that there are no agreements or understandings related to options or derivatives concerning voting rights or future securities acquisitions. The disclosure emphasizes compliance with takeover rules amid ongoing market activities.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.